Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 41.56 -0.47 (-1.12%) Market Cap: 2.02 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 8.69 GF Score: 51/100

Q4 2021 Mirum Pharmaceuticals Inc Earnings Call Transcript

Mar 09, 2022 / 09:30PM GMT
Release Date Price: $22.8 (+7.55%)
Operator

Good afternoon, and thank you for attending today's Mirum Pharmaceuticals Fourth Quarter Business Update Call. My name is Amber, and I will be your moderator for today's call. (Operator Instructions)

It is now my pleasure to hand the conference over to our host, Ian Clements, CFO of Mirum Pharmaceuticals. Ian, please proceed.

Ian Clements
Mirum Pharmaceuticals, Inc. - CFO

Thanks, Amber, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals fourth quarter and year-end 2021 conference call. I'm joined today by our President and CEO, Chris Peetz; our Chief Operating Officer, Peter Radovich; and our Head of R&D, Pam Vig.

Earlier this afternoon, Mirum issued a news release announcing the Company's results for fourth quarter and full year ended December the 31st, 2021. Copies of this news release and SEC filings can be found in the Investors section of our website.

Before we begin, I'd like to remind you that during the course of this conference call, we will be making certain forward-looking statements about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot